Journal article
The Impact of Chronic Obstructive Pulmonary Disease on Immune Checkpoint Inhibitor Effectiveness in Non-small Cell Lung Cancer: A Population Health Study
Abstract
SUMMARY: Chronic obstructive pulmonary disease (COPD) and lung cancer are associated diseases. COPD confers a negative prognosis in NSCLC, but the clinical benefit of immune checkpoint inhibitors (ICI) in this population is unclear. A population-level analysis of patients in Ontario, Canada was performed through the ICES (formerly known as the Institute for Clinical Evaluative Sciences) administrative database. Patients with NSCLC and treated …
Authors
Chan SWS; Pond GR; Goffin JR
Journal
Journal of Immunotherapy, Vol. 48, No. 4, pp. 138–146
Publisher
Wolters Kluwer
Publication Date
5 2025
DOI
10.1097/cji.0000000000000551
ISSN
1524-9557